YS Biopharma Co., Ltd. (YS) Stock Analysis
DELISTED
What happened to YS Biopharma Co., Ltd. (YS) stock?
YS Biopharma Co., Ltd. (YS) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $192M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
YS Biopharma Co., Ltd. (YS). YS Biopharma Co., Ltd. is a biopharmaceutical company focused on developing vaccines and therapeutic biologics for infectious diseases and cancer.
Last analyzed: Mar 17, 2026Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
YS Biopharma Co., Ltd. (YS) Healthcare & Pipeline Overview
YS Biopharma Co., Ltd. ADR Information Sponsored
YS Biopharma Co., Ltd. (YS) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 2
- ADR Ratio: 1:1
More about this archive record
Can I still buy YS shares?
No. YS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for YS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before YS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to YS Biopharma Co., Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.